A critical discovery in cancer study is arising with the use of nanobodies to re-engage dysfunctional p53. This essential cancer protector protein is frequently inactivated in many types of cancer, resulting https://atozbookmark.com/story21797918/vhh-fragments-reactivate-the-p53-protein-a-promising-pathway-for-malignant-therapy